481 related articles for article (PubMed ID: 17096730)
1. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
2. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma.
Siriwardena BS; Kudo Y; Ogawa I; Tilakaratne WM; Takata T
Oral Oncol; 2009 Feb; 45(2):103-8. PubMed ID: 18486530
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin.
Tanahashi J; Daa T; Yada N; Kashima K; Kondoh Y; Yokoyama S
J Oral Pathol Med; 2008 Oct; 37(9):565-70. PubMed ID: 18284543
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of β-catenin in this unusual lesion of the jaws.
Harnet JC; Pedeutour F; Raybaud H; Ambrosetti D; Fabas T; Lombardi T
J Oral Maxillofac Surg; 2013 Apr; 71(4):706-13. PubMed ID: 23265580
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
[TBL] [Abstract][Full Text] [Related]
11. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
[TBL] [Abstract][Full Text] [Related]
12. Ameloblastin gene (AMBN) mutations associated with epithelial odontogenic tumors.
Perdigão PF; Gomez RS; Pimenta FJ; De Marco L
Oral Oncol; 2004 Sep; 40(8):841-6. PubMed ID: 15288841
[TBL] [Abstract][Full Text] [Related]
13. Odontogenic tumors: analysis of 706 cases.
Regezi JA; Kerr DA; Courtney RM
J Oral Surg; 1978 Oct; 36(10):771-8. PubMed ID: 280645
[TBL] [Abstract][Full Text] [Related]
14. Malignant odontogenic tumors. A retrospective and collaborative study of seven cases.
Mosqueda Taylor A; Meneses García A; Ruíz Godoy Rivera LM; Suárez Roa Mde L; Luna Ortiz K
Med Oral; 2003; 8(2):110-21. PubMed ID: 12618671
[TBL] [Abstract][Full Text] [Related]
15. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
16. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
Kumamoto H; Ooya K
Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors.
Kumamoto H; Yoshida M; Ooya K
Oral Dis; 2001 May; 7(3):171-6. PubMed ID: 11495193
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas.
Sekine S; Sato S; Takata T; Fukuda Y; Ishida T; Kishino M; Shibata T; Kanai Y; Hirohashi S
Am J Pathol; 2003 Nov; 163(5):1707-12. PubMed ID: 14578169
[TBL] [Abstract][Full Text] [Related]
19. Localization of beta catenin across the domain of odontogenic lesions: A systematic review.
Chatterjee S; Devi A; Kamboj M; Narwal A
J Oral Pathol Med; 2023 Nov; 52(10):904-910. PubMed ID: 37840228
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.
Su TH; Chang JG; Yeh KT; Lin TH; Lee TP; Chen JC; Lin CC
Oncol Rep; 2003; 10(5):1195-200. PubMed ID: 12883680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
